Konrad Kijewski, MD
Interventional Pain Medicine · Louisville, KYNPI 1184767048
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 217 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by Abbott at 29.2% of the total. Reporting peaked in 2021 at $2,037 and has fallen 86.0% since, to $285 in 2025.
Across 217 payments — averaging $26.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Amgen$538
- Si-bone, Inc.$516
- Biohaven Pharmaceuticals, Inc.$379
- Nevro Corp.$307
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$301
- plus $2K from 26 others
What the payments were for
- Food & beverage$5,50696%
- Education$2104%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 54 | $1,667 |
| Amgen | 11 | $538 |
| Si-bone, Inc. | 15 | $516 |
| Biohaven Pharmaceuticals, Inc. | 7 | $379 |
| Nevro Corp. | 5 | $307 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $301 |
| AbbVie(2 entities) | 14 | $265 |
| Boston Scientific | 20 | $256 |
| Collegium Pharmaceutical, Inc. | 17 | $230 |
| Bioventus LLC | 1 | $136 |
| Lilly USA, LLC | 6 | $132 |
| Treace Medical Concepts, Inc. | 1 | $127 |
| Pfizer | 8 | $116 |
| Merck | 1 | $103 |
| Currax Pharmaceuticals LLC | 6 | $84 |
| Vertex | 3 | $72 |
| Novartis | 4 | $64 |
| Teva Pharmaceuticals USA, Inc. | 4 | $59 |
| Arbor Pharmaceuticals, Inc. | 3 | $49 |
| Scilex Pharmaceuticals Inc. | 3 | $48 |
| Redhill Biopharma Inc. | 2 | $43 |
| Averitas Pharma Inc. | 2 | $42 |
| Trevena, Inc. | 1 | $29 |
| Baudax Bio Inc. | 2 | $24 |
| GRT US Holding, Inc. | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $18 |
| Pacira Therapeutics, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $16 |
| Zyla Life Sciences, Inc. | 1 | $15 |
| Biodelivery Sciences International, Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $13 |
| Kaleo, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AIMOVIG$461
- NURTEC ODT$349
- iFuse Implant$244
- Proclaim IPG$144
- Durolane$136
- Lapiplasty System$127
- Senza$110
- Prodigy Family of SCS IPGs$108
- BRIDION$103
How this compares
$5,716 in reported general payments places this provider in the 65th percentile of 55 interventional pain medicine providers in Kentucky.
See all interventional pain medicine providers in Kentucky →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 428 | $7,387 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 192 | $3,890 |
| Gabapentin | 188 | $1,859 |
| Celecoxib | 15 | $743 |
| Tizanidine Hcl | 94 | $685 |
| Pregabalin | 33 | $646 |
| Tramadol Hcl | 102 | $612 |
| Meloxicam | 58 | $312 |
| Methylprednisolone | 49 | $289 |
| Oxycodone Hcl | 12 | $231 |
| Duloxetine Hcl | 20 | $220 |
| Diclofenac Sodium | 17 | $178 |
| Cyclobenzaprine Hcl | 28 | $174 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 11 | $75 |
| Amitriptyline Hcl | 13 | $60 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Louisville
- Nathan LambornLouisville$10K
- Brandon SuttonLouisville$9K
- Gary ReasorLouisville$9K
- Kristal WilsonLouisville$9K
- Blake FechtelLouisville$6K
- Lady Christine Ong SioLouisville$5K
- Jeffrey BergLouisville$3K
- Aaron ComptonLouisville$3K
- Daniel LynchLouisville$3K
- Bill HaneyLouisville$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.